CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

TB Guidelines

On this Page:

HIV / AIDS

Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis PDF
Reported HIV Status of Tuberculosis Patients — United States, 1993–2005 - MMWR 2007; 56 (No. 42)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5642a2.htm?s_cid=mm5642a2_e
PDF
Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health Care Settings - MMWR 2006; 55 (No. RR-14)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm
PDF
Screening HIV-Infected Persons for Tuberculosis — Cambodia, January 2004–February 2005 - MMWR 2005; 54 (RR46)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5446a2.htm
PDF
Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents - MMWR 2004; 53 (RR15)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5315a1.htm
PDF
Treating Opportunistic Infections Among HIV-Exposed and Infected Children - MMWR 2004; 53 (RR14)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5314a1.htm
PDF
Notice to Readers: Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors - MMWR 2004; 53 (No. 2)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5302a6.htm
PDF
Guidelines for Preventing Opportunistic Infections Among HIV-Infected Persons --- 2002 - MMWR 2002; 51 (No. RR-8)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5108a1.htm
PDF

 

Archived HIV / AIDS

The documents listed below are historical, archived information. The information contained in these documents, while accurate at the time of release, may not be the most current available.

Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors - MMWR 2000; 49 (No. 9)
www.cdc.gov/mmwr/preview/mmwrhtml/mm4909a4.htm
PDF
Prevention and Treatment of Tuberculosis among Patients Infected with Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations - MMWR 1998;  47 (No. RR-20)
www.cdc.gov/mmwr/preview/mmwrhtml/00055357.htm
PDF

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333